Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Suprazygomatic maxillary nerve block with versus without dexamethasone in endoscopic sinus surgery
PACTR202412753221505Phase 1Not yet recruiting
- Sponsor
- Alzahraa University Hospital
- Start
- Aug 2023
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of dexamethasone in paranasal sinus disease (2 arms), sponsored by Alzahraa University Hospital. Primary endpoints: Intra-operative hemodynamic stability, Intra-operative analgesia consumption and 6 more. Planned start Aug 2023; status: not yet recruiting.
02
Drugs
dexamethasone
03
Conditions
paranasal sinus disease
Beyond the preview
Go deeper on PACTR202412753221505.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202412753221505.